Riam Shammaa

Director/Board Member presso DEFENCE THERAPEUTICS INC.

Health Technology

Profilo

Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.

Posizioni attive di Riam Shammaa

Società	Posizione	Inizio
DEFENCE THERAPEUTICS INC.	Director/Board Member	09/11/2021
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Chief Executive Officer	04/02/2019

Tutte le posizioni attive di Riam Shammaa

Precedenti posizioni note di Riam Shammaa

Società	Posizione	Fine
Pallianera Pharma, Inc.	Founder	-

Vedi nel dettaglio l'esperienza di Riam Shammaa

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Riam Shammaa

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
DEFENCE THERAPEUTICS INC.	Health Technology

Aziende private	2
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Health Technology
Pallianera Pharma, Inc.